IRIS Accounts Production v24.1.9.2 04280406 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false 'A' Ordinary 1.00000 'B' Ordinary 1.00000 'C' Ordinary 1.00000 'D' Ordinary 1.00000 'E' Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh042804062023-03-31042804062024-03-31042804062023-04-012024-03-31042804062022-03-31042804062022-04-012023-03-31042804062023-03-3104280406ns15:EnglandWales2023-04-012024-03-3104280406ns14:PoundSterling2023-04-012024-03-3104280406ns10:Director12023-04-012024-03-3104280406ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3104280406ns10:SmallEntities2023-04-012024-03-3104280406ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3104280406ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3104280406ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3104280406ns10:FullAccounts2023-04-012024-03-3104280406ns10:OrdinaryShareClass12023-04-012024-03-3104280406ns10:OrdinaryShareClass22023-04-012024-03-3104280406ns10:OrdinaryShareClass32023-04-012024-03-3104280406ns10:OrdinaryShareClass42023-04-012024-03-3104280406ns10:OrdinaryShareClass52023-04-012024-03-3104280406ns10:Director22023-04-012024-03-3104280406ns10:Director32023-04-012024-03-3104280406ns10:Director42023-04-012024-03-3104280406ns10:Director52023-04-012024-03-3104280406ns10:CompanySecretary12023-04-012024-03-3104280406ns10:RegisteredOffice2023-04-012024-03-3104280406ns5:CurrentFinancialInstruments2024-03-3104280406ns5:CurrentFinancialInstruments2023-03-3104280406ns5:ShareCapital2024-03-3104280406ns5:ShareCapital2023-03-3104280406ns5:CapitalRedemptionReserve2024-03-3104280406ns5:CapitalRedemptionReserve2023-03-3104280406ns5:RetainedEarningsAccumulatedLosses2024-03-3104280406ns5:RetainedEarningsAccumulatedLosses2023-03-3104280406ns5:PlantMachinery2023-04-012024-03-3104280406ns5:LeaseholdImprovements2023-03-3104280406ns5:PlantMachinery2023-03-3104280406ns5:ComputerEquipment2023-03-3104280406ns5:LeaseholdImprovements2023-04-012024-03-3104280406ns5:ComputerEquipment2023-04-012024-03-3104280406ns5:LeaseholdImprovements2024-03-3104280406ns5:PlantMachinery2024-03-3104280406ns5:ComputerEquipment2024-03-3104280406ns5:LeaseholdImprovements2023-03-3104280406ns5:PlantMachinery2023-03-3104280406ns5:ComputerEquipment2023-03-3104280406ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3104280406ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3104280406ns5:CurrentFinancialInstruments2023-04-012024-03-3104280406ns10:OrdinaryShareClass12024-03-3104280406ns10:OrdinaryShareClass22024-03-3104280406ns10:OrdinaryShareClass32024-03-3104280406ns10:OrdinaryShareClass42024-03-3104280406ns10:OrdinaryShareClass52024-03-31
REGISTERED NUMBER: 04280406 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2024

FOR

MINTA MEDICAL LIMITED

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024










Page

Company Information 1

Balance Sheet 2 to 3

Notes to the Financial Statements 4 to 7


MINTA MEDICAL LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2024







DIRECTORS: R Edwards
M A Edwards
A R Edwards
Mrs I J Edwards
Mrs T Edwards





SECRETARY: M A Edwards





REGISTERED OFFICE: Caddick Road
Knowsley Business Park
Knowsley
Merseyside
L34 9HP





REGISTERED NUMBER: 04280406 (England and Wales)

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

BALANCE SHEET
31 MARCH 2024

31.3.24 31.3.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 171,687 182,789

CURRENT ASSETS
Stocks 1,688,418 1,576,124
Debtors 5 595,869 991,475
Cash at bank and in hand 317,693 371,569
2,601,980 2,939,168
CREDITORS
Amounts falling due within one year 6 313,604 410,006
NET CURRENT ASSETS 2,288,376 2,529,162
TOTAL ASSETS LESS CURRENT
LIABILITIES

2,460,063

2,711,951

PROVISIONS FOR LIABILITIES 14,935 15,268
NET ASSETS 2,445,128 2,696,683

CAPITAL AND RESERVES
Called up share capital 7 7,500 7,500
Capital redemption reserve (123,635 ) (123,635 )
Retained earnings 2,561,263 2,812,818
SHAREHOLDERS' FUNDS 2,445,128 2,696,683

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

BALANCE SHEET - continued
31 MARCH 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 18 June 2024 and were signed on its behalf by:





M A Edwards - Director


MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2024


1. STATUTORY INFORMATION

Minta Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 20% on reducing balance and 5% on cost

Fixed assets are initially recognised at cost.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 24 (2023 - 23 ) .

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


4. TANGIBLE FIXED ASSETS
Improvements
to Plant and Computer
property machinery equipment Totals
£    £    £    £   
COST
At 1 April 2023 173,803 213,233 25,378 412,414
Additions - 14,782 1,955 16,737
At 31 March 2024 173,803 228,015 27,333 429,151
DEPRECIATION
At 1 April 2023 70,012 143,763 15,850 229,625
Charge for year 8,691 16,851 2,297 27,839
At 31 March 2024 78,703 160,614 18,147 257,464
NET BOOK VALUE
At 31 March 2024 95,100 67,401 9,186 171,687
At 31 March 2023 103,791 69,470 9,528 182,789

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade debtors 573,330 941,112
Other debtors 22,539 50,363
595,869 991,475

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.24 31.3.23
£    £   
Trade creditors 115,947 95,649
Taxation and social security 157,725 274,158
Other creditors 39,932 40,199
313,604 410,006

Other creditors include £3,597 in respect of pension contributions (2023 £4,336).

MINTA MEDICAL LIMITED (REGISTERED NUMBER: 04280406)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2024


7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.3.24 31.3.23
value: £    £   
1,250 'A' Ordinary £1 1,250 1,250
1,250 'B' Ordinary £1 1,250 1,250
1,250 'C' Ordinary £1 1,250 1,250
1,250 'D' Ordinary £1 1,250 1,250
1,250 'E' Ordinary £1 1,250 1,250
1,250 'F' Ordinary £1 1,250 1,250
7,500 7,500

8. RELATED PARTY DISCLOSURES

During the year, dividends totalling £1,711,878 (2023 £1,703,857) were paid to the directors.

During the year, the company paid rent of £71,006 to the directors.

9. ULTIMATE CONTROLLING PARTY

The company was controlled throughout the period by the directors.